MRC Highlight Notice: Researching ME/CFS

Closing Date: –

Support for high-quality funding applications in ME/CFS research to any of the MRC’s grants from MRC research boards or MRC fellowships.

The Medical Research Council (MRC) operates the Researching ME/CFS highlight notice to enable applicants to research myalgic encephalomyelitis/chronic fatigue syndrome, also known as ME/CFS.

Applicants can access funding either through:

  • Grants from MRC research boards; or
  • MRC fellowships

Proposals are particularly sought that lie within MRC remit and address one or more of the following research areas identified by the 2022 ME/CFS Priority Setting Partnership for ME/CFS research:

  • Post-exertional malaise.
  • Use of existing drugs for other conditions.
  • Diagnosis.
  • Autoimmunity.
  • ME/CFS sub-types.
  • Post-infective cause.
  • Neurological symptomology.
  • Genetics.
  • Severe ME/CFS.
  • Mitochondrial dysfunction.
  • Oxygenation dysfunction.

Research proposals should consider how to:

  • Increase capacity in ME/CFS research.
  • Address the need for multidisciplinary teams to tackle the significant research challenges in this area.
  • Involve persons living with ME/CFS in developing ME/CFS research proposals.

Research proposals may involve partnerships between ME/CFS researchers and established, leading investigators working in relevant areas, but who are new to the ME/CFS field.

Funding body Medical Research Council (MRC)
Maximum value Discretionary
Reference ID S25555
Category Medical Research
Fund or call Fund